Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 14/20 | 0.88 |
| ▸ | STING1 | Q86WV6 | 3/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | ELAVL3 | Q14576 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9885103 | 0.94 | ABCB1 (1.00) | ABCB1STING1ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL9885702 | 0.94 | ABCB1 (1.00) | ABCB1STING1ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL20581484 | 0.91 | ABCB1 (0.94) | ABCB1STING1ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL4494815 | 0.91 | ABCB1 (0.94) | ABCB1STING1ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL4494818 | 0.91 | ABCB1 (0.94) | ABCB1STING1ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL4494812 | 0.91 | ABCB1 (0.94) | ABCB1STING1ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL4481090 | 0.87 | ABCB1 (0.87) | ABCB1STING1ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL9100176 | 0.87 | ABCB1 (0.87) | ABCB1STING1ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL4481085 | 0.87 | ABCB1 (0.87) | ABCB1STING1ALDH1A1CYP3A4MAPK1 | |
| SCHEMBL4484373 | 0.87 | ABCB1 (0.87) | ABCB1STING1ALDH1A1CYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210085640-A1 | ACYLATED CATECHIN POLYPHENOLS AND METHODS OF THEIR USE FOR THE TREATMENT OF CANCER | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210085640-A1 | ACYLATED CATECHIN POLYPHENOLS AND METHODS OF THEIR USE FOR THE TREATMENT OF CANCER | ACAT2, ACAT1, FABP6 | ABCB1 2013/4885STING1 4081/4885ALDH1A1 290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.